{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:58:37Z","timestamp":1787500717235,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To review phenotyping and risk classification of penicillin allergy and provide an update on penicillin allergy delabeling strategies for primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Beta-lactams are considered the treatment of choice for a wide range of bacterial pathogens; however, many patients receive second-line agents due to being labeled as having an allergy to penicillin. This approach can lead to antibiotic resistance and inferior health outcomes. While 10% of the population is labeled as penicillin allergic, penicillin anaphylaxis occurs in less than 1% of patients. For patients with delayed benign skin rashes (e.g., urticaria or maculopapular exanthem &gt;1\u200ah after administration) attributable to beta-lactam administration occurring more than 12 months ago, direct oral challenge (rechallenge with antibiotic in the clinical setting) can be a safe and effective strategy, with immediate reactions occurring in less than 5% of such low-risk patients and delayed reactions appearing infrequently. In patients with penicillin-associated immediate urticaria, other IgE-mediated features, or anaphylaxis, further allergy evaluation and penicillin skin testing is warranted. Any severe idiosyncratic cutaneous adverse reaction is rare, but can be dangerous so prompt removal of the inciting agent is required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Penicillin allergy delabeling is a high-value service that can be effectively delivered through a multidisciplinary collaborative approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000000879","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T05:41:20Z","timestamp":1581918080000},"page":"321-327","source":"Crossref","is-referenced-by-count":17,"title":["Update on penicillin allergy delabeling"],"prefix":"10.1097","volume":"32","author":[{"given":"Marcus","family":"Shaker","sequence":"first","affiliation":[{"name":"The Geisel School of Medicine at Dartmouth, Hanover"},{"name":"Children's Hospital at Dartmouth, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"McWilliams","sequence":"additional","affiliation":[{"name":"The Geisel School of Medicine at Dartmouth, Hanover"},{"name":"Children's Hospital at Dartmouth, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[{"name":"Section of Allergy and Immunology, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2017-2497","article-title":"Antibiotic allergy in pediatrics","volume":"141","author":"Norton","year":"2018","journal-title":"Pediatrics"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.anai.2018.07.041","article-title":"Who needs penicillin allergy testing?","volume":"121","author":"Macy","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaip.2018.05.008","article-title":"Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing","volume":"7","author":"Iammatteo","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R5-20230918","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis \u2013 a 2020 practice parameter update, systematic review, and GRADE analysis","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2016.04.029","article-title":"Trends, characteristics, and incidence of anaphylaxis in 2001\u20132010: a population-based study","volume":"139","author":"Lee","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999\u20132010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jac\/dkm315","article-title":"Results of a UK survey of fatal anaphylaxis after oral amoxicillin","volume":"60","author":"Lee","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"e160033","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaip.2017.11.039","article-title":"The penicillin allergy label: expensive to maintain, inexpensive to remove","volume":"6","author":"Jefferson","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/cid\/cix794","article-title":"The impact of a reported penicillin allergy on surgical site infection risk","volume":"66","author":"Blumenthal","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaip.2018.04.042","article-title":"Long-term follow-up after penicillin allergy delabeling in ambulatory patients","volume":"7","author":"Lachover-Roth","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R14-20230918","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3466","article-title":"Antibiotic use after removal of penicillin allergy label","volume":"141","author":"Vyles","year":"2018","journal-title":"Pediatrics"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaip.2017.02.012","article-title":"The effect of penicillin allergy testing on future healthcare utilization: a matched cohort study","volume":"5","author":"Macy","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.anai.2019.08.005","article-title":"Safety of direct drug provocation testing in adults with penicillin allergy and association with health and economic benefits","volume":"123","author":"Li","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"S548","DOI":"10.1067\/mai.2003.93","article-title":"10. Drug allergy","volume":"111","author":"Gruchalla","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0300-483X(00)00400-5","article-title":"Gell and Coombs's classification: is it still valid?","volume":"158","author":"Descotes","year":"2001","journal-title":"Toxicology"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2016-4006","article-title":"Section on allergy and immunology. Epinephrine for first-aid management of anaphylaxis","volume":"139","author":"Sicherer","year":"2017","journal-title":"Pediatrics"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.jaip.2019.04.018","article-title":"Evaluation of prehospital management in a Canadian Emergency Department Anaphylaxis Cohort","volume":"7","author":"Gabrielli","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaip.2013.11.008","article-title":"Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms","volume":"2","author":"Galvao","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"723062","DOI":"10.1155\/2012\/723062","article-title":"The link between hypersensitivity syndrome reaction development and human herpes virus-6 reactivation","volume":"2012","author":"Pritchett","year":"2012","journal-title":"Int J Hepatol"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.coi.2012.07.010","article-title":"Drug reaction with eosinophilia and systemic symptoms: an update on pathogenesis","volume":"24","author":"Camous","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.acap.2016.11.004","article-title":"Parent-reported penicillin allergy symptoms in the pediatric emergency department","volume":"17","author":"Vyles","year":"2017","journal-title":"Acad Pediatr"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jaip.2019.03.015","article-title":"Identifying low-risk beta-lactam allergy patients in a UK Tertiary Centre","volume":"7","author":"Siew","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2017-0471","article-title":"Allergy testing in children with low-risk penicillin allergy symptoms","volume":"140","author":"Vyles","year":"2017","journal-title":"Pediatrics"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaip.2017.02.023","article-title":"Oral challenge without skin testing safely excludes clinically significant delayed-onset penicillin hypersensitivity","volume":"5","author":"Confino-Cohen","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anai.2017.10.020","article-title":"Administration of influenza vaccines to egg allergic recipients: a practice parameter update 2017","volume":"120","author":"Greenhawt","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.jaip.2019.06.018","article-title":"Optimizing penicillin allergy delabeling: one big step forward and several small steps sideways","volume":"7","author":"Macy","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-019-0854-6","article-title":"Evaluating penicillin allergies without skin testing","volume":"19","author":"Banks","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jaip.2019.04.006","article-title":"Risk-based pathway for outpatient penicillin allergy evaluations","volume":"7","author":"Blumenthal","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.jaip.2019.06.026","article-title":"Limited utility of prolonged drug provocations in beta-lactam allergy: a global perspective","volume":"7","author":"Guyer","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jaip.2019.04.021","article-title":"The limited value of prolonged drug challenges in nonimmediate amoxicillin (clavulanic acid) hypersensitivity","volume":"7","author":"Van Gasse","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.2019.4542","article-title":"Evaluation of patients with a history of penicillin allergy-reply","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jaip.2019.05.037","article-title":"Comparing direct challenge to penicillin skin testing for the outpatient evaluation of penicillin allergy: a randomized controlled trial","volume":"7","author":"Mustafa","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra993637","article-title":"Cephalosporin allergy","volume":"345","author":"Kelkar","year":"2001","journal-title":"N Engl J Med"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaip.2017.07.033","article-title":"Are cephalosporins safe for use in penicillin allergy without prior allergy evaluation?","volume":"6","author":"Macy","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jaci.2009.10.028","article-title":"Drug allergy","volume":"125","author":"Khan","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jaip.2019.06.001","article-title":"Cephalosporin allergy: current understanding and future challenges","volume":"7","author":"Khan","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/jcpt.12530","article-title":"Next step in antibiotic stewardship: pharmacist-provided penicillin allergy testing","volume":"42","author":"Gugkaeva","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/ajhp\/61.12.1271","article-title":"Pharmacist-managed service providing penicillin allergy skin tests","volume":"61","author":"Wall","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/jac\/dky575","article-title":"Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital","volume":"74","author":"du Plessis","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/jac\/dkz082","article-title":"Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention","volume":"74","author":"Devchand","year":"2019","journal-title":"J Antimicrob Chemother"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T22:15:14Z","timestamp":1694988914000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000879","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}